Doctors from the University of Edinburgh and local intensive care units have linked to fight an antibiotic-resistant infection which attacks some hospital patients. The scientists aim to find new treatments for ventilator-associated pneumonia (VAP) at a time when bacteria resistant to antibiotics are emerging faster than the pharmaceutical industry can produce new drugs to combat hospital-acquired infections. It is estimated that as many as 20 percent of patients who require treatment on a ventilator machine may develop VAP and the infection is fatal in a high proportion of these patients.
The lung is known to make its own antibacterial substances, but these are overwhelmed by bacteria during severe infection. The new five-year Edinburgh study, which begins in May, will look first at the way the lung produces antibacterial substances. Researchers then hope to discover which of the lung's natural antibiotics are most deficient during severe pneumonia and design the best ways to deliver genes producing these antibiotics to the diseased lung.
Dr John Simpson, leading the project, explained, " We plan to boost expression of these naturally occurring genes in white blood cells which are programmed to travel from the bloodstream to the infected lung. In this way, the `highjacked' blood cells will carry the antibiotic genes to exactly where they are most needed. We will take blood and samples of fluid from the lungs of patients with VAP to see if natural antibiotics and the cells which fight infection are able to function normally in their infected environment. The next step is to identify the best combination of therapeutic genes to be developed in the laboratory, in the hope that we can make the body's cells and natural antibiotics clear severe pneumonia more efficiently. We hope that studying patients and healthy volunteers will pave the way for clinical trials of gene therapy for VAP, towards the end of the five-year program. If successful, we could use the knowledge to tackle other hospital-acquired infections."
Simpson, a senior clinical lecturer and honorary consultant in respiratory medicine, was awarded the Sir Jules Thorn Award for Biomedical Research 2003, the first time the award has been made to a Scottish University. The £970,000 award from the Sir Jules Thorns Charitable Trust, an independent medical research charity, will support the five-year research program.
Source: University of Edinburgh
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.